An article 5 published journal of Thoracic Oncology, in November, 2010, researchers at the Medical Center University of Rochester, reported that patients with malignant pleural mesothelioma, tumor grade and directed by cancer operation overall survival have the greatest impact on your. Researchers found further that women, younger patients (age was not specified) and those with Epithelioid mesothelioma the best prognosis type. Epithelioid mesothelioma is the most common and treatable histological subtype of mesothelioma.
Mesothelioma is a serious cancer that exposed occurs in individuals, the airborne asbestos fibres. The disease is very aggressive and is resistant to many standard cancer treatments so that there is a difficult disease to treat effectively. Many factors set, while the average survival time usually from 4 – 18 months after diagnosis of mesothelioma varies, the life expectancy. Factors that are identified to plan if the patient has ever smoked type and level of mesothelioma treatment previously, lifestyle, nutrition and fitness level of the patients, as well as age, gender and family traits.
Researchers analyzed total 9,701 patients with malignant pleural mesothelioma diagnosed from 1973 to 2006, with the aim of which survive General and influence variables to characterize survival in patients with pleural mesothelioma. The survival rate for 6 months, 1 year to 5 years that review results found that survive 55, 33 and 5%, or was.
The "negative prognostic factors" contain age males, higher tumor grade, nonepithelioid histology, higher level, no directed by cancer surgery and no radiation therapy. This is the need for better screening methods for mesothelioma, finding how positively a patient treatments survive early detection by increasing and improving quality of life in the fight against cancer can affect.
The Department of radiation oncology at the James p. Wilmot Cancer Center of the University of Rochester is recognized nationally as one of the leading institutions in radiation technology, treatment and research in radiation and cancer biology. Their mission "is" to cure cancer, while always with the aim of the quality of life, these objectives promote exercising the science of cancer therapy through clinical and basic research ahead and young oncologists to improve if possible.
